This article was originally published in The Tan Sheet
Damage assessments not yet complete following industrial accident at contract packager of Columbia Labs' vaginal gel products Replens,RepHresh, Advantage-S, Livingston, N.J.-based firm says Nov. 25. Accident, in which a work train collided with Maropack, Inc.'s packaging facility in Zell, Switzerland, may affect product availability and Q4 sales to strategic partners outside U.S. and domestic trade customers, Columbia Labs says. No impact is expected on product availability to consumers in 2002, or on 2003 production or sales, according to firm...
You may also be interested in...
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.